医学
彭布罗利珠单抗
伦瓦提尼
卵巢癌
肿瘤科
内科学
临床研究阶段
妇科
癌症
临床试验
免疫疗法
甲状腺癌
作者
Antonio González‐Martín,Hyun Cheol Chung,Esma Saada‐Bouzid,Eduardo Yáñez,Hélène Senellart,Philippe Cassier,Bristi Basu,Bradley R. Corr,Eugenia Girda,Corina E. Dutcus,Chinyere E. Okpara,Razi Ghori,Fan Jin,Roman Groisberg,Zarnie Lwin
标识
DOI:10.1016/j.ygyno.2024.04.011
摘要
The phase 2, multicohort, open-label LEAP-005 study evaluated lenvatinib plus pembrolizumab in patients with previously treated advanced solid tumors. We report outcomes from the ovarian cancer cohort.
科研通智能强力驱动
Strongly Powered by AbleSci AI